|Articles|October 2, 2015
- BioPharm International-10-15-2015
- Volume 2015 eBook
- Issue 2
Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations
Author(s)Daniel Some, Russell Burge
This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.
Advertisement
BioPharm International
eBooks Volume 28, Issue 14
Assessing a drug candidate’s suitability during preformulation is essential to minimize the risk of costly downstream failure. Stability is a defining feature of biotherapeutic performance; measuring formulation stability during early-phase screening allows developers to make robust predictions of suitability for further development. Read this article and other articles in
BioPharm International
's 2015
eBook.
Articles in this issue
about 10 years ago
Fluctuating Capacity and Demand Conditions in Biomanufacturingabout 10 years ago
Cleaning Validation for Biologicsabout 10 years ago
Automation of Single-Use Systemsabout 10 years ago
Are Biopharma Patents Poised on the Post-Grant Chopping Block?about 10 years ago
Raising the Bar for Biopharma TrainingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Ask the Expert: Commenting on Draft Regulations
2
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
3
Behind the Headlines Episode 27: Unpacking Mega Deals and R&D Directions
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
